Centre Hospitalier Universitaire de Besancon
Besançon, 25000, France
Location status: Recruiting
NCT Number: NCT05860894
Atrial fibrillation (AF) is a common heart rhythm disorder in the intensive care unit (ICU). It can be precipitated by multiple factors but it is unclear whether AF persists after discharge from the ICU, and long term. This study will investigate whether AF recurs up to one year after ICU discharge.
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
Besançon, 25000, France
Location status: Recruiting
Atrial fibrillation (AF) is the most common heart rhythm disorder encountered in the intensive care unit (ICU). It can be precipitated by multiple factors present in critically ill patients, such as tissue hypoxia, metabolic disorders etc. There is a paucity of data regarding the persistence of AF in these patients after discharge from the ICU, and in the longer term. Therefore, this study will investigate whether AF recurs up to one year after ICU discharge using an implantable ECG Holter device in adult patients discharged alive from the ICU, with documented new onset AF.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Subcutaneous implantation of ECG holder device to monitor ECG
Time frame: up to 1 year after ICU discharge
Any episode of atrial fibrillation, atrial tachycardia or atrial flutter lasting at least 1 minute, as documented on the implantable device recordings
Time frame: up to 2 years after ICU discharge
Burden of atrial fibrillation assessed as time (in days, hours and minutes), expressed as a absolute value
Time frame: up to 2 years after ICU discharge
Burden of atrial fibrillation assessed as time (in days, hours and minutes) expressed as a percentage time spent in atrial fibrillation
Time frame: up to 2 years after ICU discharge
Ischemic or hemorrhagei stroke documented by imaging, major bleeding (ISTH classification) or documented peripheral emboli
Time frame: up to 2 years after ICU discharge
Changes in treatment due to the discovery of atrial fibrillation
Contact information is provided by the study sponsor or research team.
Charles Monnin, MD
CONTACT
Elise Robert
CONTACT
Centre Hospitalier Universitaire de Besancon
Other
Acronym: PIAF
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05229211
Arrhythmias, Cardiac, Atrial Fibrillation
Oxford, Oxfordshire, United Kingdom
View Trial DetailsNCT05378035
Arrhythmias, Cardiac, Arterial Thromboembolism
Hong Kong
View Trial DetailsNCT07492524
Arrhythmias, Cardiac, Atrial Fibrillation
Yancheng, Dongtai, China
View Trial DetailsNCT07492498
Arrhythmias, Cardiac, Atrial Fibrillation
Yancheng, Dongtai, China
View Trial Details